DK0925065T3 - Vandblandbare erythromycinsammensætninger - Google Patents

Vandblandbare erythromycinsammensætninger

Info

Publication number: DK0925065T3
Authority: DK; Denmark
Prior art keywords: water; miscible; erythromycin compositions; compositions; miscible erythromycin
Prior art date: 1996-07-02

Application number

DK97931511T

Other languages

English (en)

Inventor

Raymond E Hopponen

Lowell R Macy

Original Assignee

Merial Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-02

Filing date

1997-07-02

Publication date

2005-10-17

1997-07-02 Application filed by Merial Ltd filed Critical Merial Ltd

2005-10-17 Application granted granted Critical

2005-10-17 Publication of DK0925065T3 publication Critical patent/DK0925065T3/da

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 4
229960003276 erythromycin Drugs 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
239000003960 organic solvent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Jellies, Jams, And Syrups (AREA)

DK97931511T 1996-07-02 1997-07-02 Vandblandbare erythromycinsammensætninger DK0925065T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/675,380 US5723447A (en)	1996-07-02	1996-07-02	Water miscible erythromycin solutions
EP97931511A EP0925065B1 (en)	1996-07-02	1997-07-02	Water miscible erythromycin compositions

Publications (1)

Publication Number	Publication Date
DK0925065T3 true DK0925065T3 (da)	2005-10-17

Family

ID=24710231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97931511T DK0925065T3 (da)	1996-07-02	1997-07-02	Vandblandbare erythromycinsammensætninger

Country Status (13)

Country	Link
US (1)	US5723447A (da)
EP (1)	EP0925065B1 (da)
JP (1)	JP2000516205A (da)
AT (1)	ATE304857T1 (da)
AU (1)	AU717148B2 (da)
BR (1)	BR9710118B1 (da)
CA (1)	CA2259430C (da)
DE (1)	DE69734242T2 (da)
DK (1)	DK0925065T3 (da)
ES (1)	ES2246515T3 (da)
NZ (1)	NZ333574A (da)
PT (1)	PT925065E (da)
WO (1)	WO1998000146A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5958888A (en) *	1996-07-02	1999-09-28	Merial, Inc.	Water miscible macrolide solutions
US6239112B1 (en) *	1998-07-09	2001-05-29	Merial, Inc.	Water miscible macrolide solutions
US6780885B1 (en) *	2000-01-14	2004-08-24	Idexx Laboratories, Inc.	Formulations and methods for administration of pharmacologically or biologically active compounds
US6914051B1 (en) *	2000-06-28	2005-07-05	David M Allen	Penetrating antibiotic gel for soft tissue diseases
JP2004506664A (ja) *	2000-08-23	2004-03-04	ウォックハート・リミテッド	無水アジトロマイシンの製造法
US6946137B2 (en) *	2001-10-19	2005-09-20	Idexx Laboratories, Inc.	Methods for the controlled delivery of pharmacologically active compounds
WO2003034988A2 (en) *	2001-10-19	2003-05-01	Idexx Laboratories, Inc.	Injectable compositions for the controlled delivery of pharmacologically active compound
US7439268B2 (en) *	2003-07-18	2008-10-21	Idexx Laboratories	Compositions containing prodrugs of florfenicol and methods of use
US20050049209A1 (en) *	2003-08-06	2005-03-03	Chen Andrew Xian	Pharmaceutical compositions for delivering macrolides
US20050049210A1 (en) *	2003-08-27	2005-03-03	Idexx Laboratories, Inc.	Methods for the controlled delivery of pharmacologically active compounds
US7282487B2 (en) *	2004-10-28	2007-10-16	Idexx Laboratories	Method for treating bacterial infections in horses or pigs with tilmicosin
US8403882B2 (en)	2005-11-22	2013-03-26	Omrix Biopharmaceuticals, S.A.	Applicator device for applying a multi-component fluid
US7550625B2 (en) *	2007-10-19	2009-06-23	Idexx Laboratories	Esters of florfenicol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU529422B2 (en) *	1978-10-20	1983-06-09	Eli Lilly And Company	Stable erythromycin solution
US4264765A (en) *	1980-02-20	1981-04-28	Abbott Laboratories	Salts of erythromycin A esters
US5175150A (en) *	1985-08-31	1992-12-29	Kitasato, Kenkyusho	Erythromycin derivative
DE19518917A1 (de) *	1995-05-23	1996-11-28	Boehringer Ingelheim Vetmed	Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen

1996
- 1996-07-02 US US08/675,380 patent/US5723447A/en not_active Expired - Lifetime
1997
- 1997-07-02 JP JP10504408A patent/JP2000516205A/ja active Pending
- 1997-07-02 CA CA002259430A patent/CA2259430C/en not_active Expired - Lifetime
- 1997-07-02 AU AU35124/97A patent/AU717148B2/en not_active Expired
- 1997-07-02 DK DK97931511T patent/DK0925065T3/da active
- 1997-07-02 AT AT97931511T patent/ATE304857T1/de active
- 1997-07-02 ES ES97931511T patent/ES2246515T3/es not_active Expired - Lifetime
- 1997-07-02 PT PT97931511T patent/PT925065E/pt unknown
- 1997-07-02 EP EP97931511A patent/EP0925065B1/en not_active Expired - Lifetime
- 1997-07-02 BR BRPI9710118-4A patent/BR9710118B1/pt not_active IP Right Cessation
- 1997-07-02 WO PCT/US1997/011460 patent/WO1998000146A1/en not_active Ceased
- 1997-07-02 NZ NZ333574A patent/NZ333574A/xx not_active IP Right Cessation
- 1997-07-02 DE DE69734242T patent/DE69734242T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0925065B1 (en)	2005-09-21
CA2259430C (en)	2008-11-18
BR9710118A (pt)	2000-01-18
EP0925065A1 (en)	1999-06-30
DE69734242T2 (de)	2006-01-26
AU717148B2 (en)	2000-03-16
ATE304857T1 (de)	2005-10-15
US5723447A (en)	1998-03-03
WO1998000146A1 (en)	1998-01-08
CA2259430A1 (en)	1998-01-08
PT925065E (pt)	2005-11-30
AU3512497A (en)	1998-01-21
ES2246515T3 (es)	2006-02-16
EP0925065A4 (en)	2000-05-10
DE69734242D1 (de)	2005-10-27
NZ333574A (en)	2000-03-27
JP2000516205A (ja)	2000-12-05
BR9710118B1 (pt)	2010-02-23

Similar Documents

Publication	Publication Date	Title
CA2336809A1 (en)	2000-01-20	Water miscible macrolide solutions
DK0925065T3 (da)	2005-10-17	Vandblandbare erythromycinsammensætninger
AR030045A1 (es)	2003-08-13	Composicion farmaceutica que contiene compuestos antibioticos de azalida , metodos para obtencion
KR920700632A (ko)	1992-08-10	메일라드 반응저해제
CA2133885A1 (en)	1995-04-09	Crystalline inclusion complex of diclofenac with beta-cyclodextrin
BR9407052A (pt)	1996-08-13	Misturas de combustiveis
KR840002350A (ko)	1984-06-25	N-아세틸시스테인의 살리실산 유도체의 제조 방법
DK314289D0 (da)	1989-06-23	Kompositioner
EP0798383A3 (en)	1999-04-28	Method for preparing an ester compound using enzyme in non-Solvent Phase
GB1433308A (en)	1976-04-28	Acetamidophenyl esters of salicylic acid derivatives
ES2174323T3 (es)	2002-11-01	Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ID16017A (id)	1997-08-28	Proses yang dimanfaatkan untuk memproduksi asam organik
KR840004121A (ko)	1984-10-06	아즈렌 유도체의 안정화 방법
PT859795E (pt)	2003-08-29	Processo para a preparacao de ferro-dextrano cristalino
FI810431L (fi)	1981-08-15	Foerfarande foer framstaellning av 3'-bromsubstituerade deacetoxicefalosporansyrasulfoxidderivat
BR9916021A (pt)	2001-10-30	Composições farmacêuticas contendo quinaprilmagnésio
CA2098959A1 (en)	1994-01-11	Compounds and methods for the site-specific photoaffinity labelling of biomolecules
DK1109782T3 (da)	2005-10-17	Fremgangsmåde til fremstilling af N-beskyttede azetidin-2-carboxylsyrer (AzeOH'er)
JPS55122758A (en)	1980-09-20	Racemization of l-alpha-methyl-beta-acylthiopropionic acid
KR850004758A (ko)	1985-07-27	피라졸로 피리딘 유도체의 제법
KR900014404A (ko)	1990-10-23	3-엑소메틸렌세팜 술폭시드 유도체 및 그것의 중간체의 제조방법
RU1807052C (ru)	1993-04-07	1,10-Фенантролинаты 4-нитрофенил-4 @ -пиридилметанидов натри или кали , обладающие индикаторными свойствами по отношению к воде или протонным органическим растворител м с интервалом перехода окраски от синей к бесцветной при рК @ 29
JPS5328101A (en)	1978-03-16	Antibiotics as-85 and its preparation
KR830005132A (ko)	1983-08-03	1-[(2-메르캅토사이클로알킬)카보닐]-l-프롤린 유도체의 제조방법
JPS53137945A (en)	1978-12-01	Purification of chenodeoxycholic acid